Detalles de la búsqueda
1.
Clinical and therapeutic value of the adjusted Global Antiphospholipid Syndrome Score in primary obstetric antiphospholipid syndrome.
Lupus
; 31(3): 354-362, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35157809
2.
Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.
Lupus
; 29(13): 1736-1742, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32838621
3.
Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality.
Clin Rheumatol
; 43(5): 1615-1622, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38436770
4.
Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome.
Clin Appl Thromb Hemost
; 14(3): 319-24, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18160600
5.
What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?
Immunol Res
; 66(5): 577-583, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30159862
6.
False positive reactions in confirmatory tests for syphilis in presence of antiphospholipid antibodies: misdiagnosis with prognostic and social consequences.
Dermatol Online J
; 12(4): 22, 2006 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-17083877
7.
The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients: a multicenter study.
Eur Cytokine Netw
; 23(1): 7-11, 2012 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22466290
8.
Role of 4G/5G promoter polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in outcome of sepsis.
Thromb Res
; 125(4): 367-9, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19410276
Resultados
1 -
8
de 8
1
Próxima >
>>